Get the Stockscreener App
41.19
1.84%
-0.77
After Hours:
41.19
Quidelortho Corporation Stock (QDEL) Latest News
Inside QuidelOrtho's Growth Strategy: Key Insights Coming at Raymond James Conference - StockTitan
Transfusion Medicine Business Development ManagerSouth Arkansas, Mississippi,and Louisiana - CollegeRecruiter.com
QuidelOrtho Corporation f/k/a Quidel Corporation Class Action: Levi & Korsinsky Reminds QuidelOrtho Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 11, 2024 – QDEL - ACCESS Newswire
QuidelOrtho Co. (NASDAQ:QDEL) Shares Purchased by State of New Jersey Common Pension Fund D - MarketBeat
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of QuidelOrtho Corporation f/k/a Quidel Corporation(QDEL) Shareholders - ACCESS Newswire
Shareholders that lost money on QuidelOrtho Corporation f/k/a Quidel Corporation(QDEL) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
QuidelOrtho: Growth Struggles And Negative GAAP Earnings Continue To Disinterest Investors - Seeking Alpha
$30+ Bn Primary Care POC Diagnostics Market Opportunities - GlobeNewswire
Why QuidelOrtho Stock Bounced More Than 4% Higher Today - MSN
QDEL SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Announces that QuidelOrtho Corporation Investors Can Join the Class Action Lawsuit! - ACCESS Newswire
QuidelOrtho Co. (NASDAQ:QDEL) Sees Significant Decrease in Short Interest - MarketBeat
In vitro diagnostics Market Poised for Significant Growth to Reach value of USD 133.24 Billion from 2025 to 2034 - GlobeNewswire Inc.
January 2026 Options Now Available For QuidelOrtho (QDEL) - Nasdaq
QuidelOrtho Co. (NASDAQ:QDEL) Receives $51.20 Average PT from Analysts - MarketBeat
QDEL Stock Earnings: QuidelOrtho Misses EPS, Beats Revenue for Q1 2024 - MSN
QuidelOrtho's SWOT analysis: stock poised for growth amid challenges - MSN
Stephens Inc. AR Acquires Shares of 14,915 QuidelOrtho Co. (NASDAQ:QDEL) - MarketBeat
QDEL DEADLINE ALERT: Bernstein Liebhard LLP Reminds QuidelOrtho Corporation Investors of Upcoming Deadline - ACCESS Newswire
QuidelOrtho (NASDAQ:QDEL) Trading Down 4.9% Following Analyst Downgrade - MarketBeat
QuidelOrtho (NASDAQ:QDEL) Shares Gap Up Following Analyst Upgrade - MarketBeat
QuidelOrtho (NASDAQ:QDEL) Price Target Raised to $45.00 - MarketBeat
18,856 Shares in QuidelOrtho Co. (NASDAQ:QDEL) Acquired by Legato Capital Management LLC - MarketBeat
QuidelOrtho (NASDAQ:QDEL) Cut to Hold at StockNews.com - MarketBeat
QuidelOrtho's SWOT analysis: stock poised for growth amid challenges By Investing.com - Investing.com South Africa
QDEL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that QuidelOrtho Corporation Investors Can Join the Class Action Lawsuit! - ACCESS Newswire
QuidelOrtho (NASDAQ:QDEL) Issues FY 2025 Earnings Guidance - MarketBeat
QuidelOrtho (NASDAQ:QDEL) Issues Quarterly Earnings Results, Misses Estimates By $0.44 EPS - MarketBeat
QuidelOrtho projects $2.6B-$2.81B revenue for 2025 supported by cost savings and margin expansion - MSN
QuidelOrtho (NASDAQ:QDEL) Announces Quarterly Earnings Results - MarketBeat
QuidelOrtho 2025 EPS, revenue guidance ranges include consensus - MSN
QuidelOrtho Full Year 2024 Earnings: EPS Misses Expectations - Simply Wall St
Lightrock Netherlands B.V. Takes $10.05 Million Position in QuidelOrtho Co. (NASDAQ:QDEL) - MarketBeat
QuidelOrtho (QDEL) Q4 Earnings and Revenues Top Estimates - MSN
QuidelOrtho Corporation (NASDAQ:QDEL) Q4 2024 Earnings Call Transcript - MSN
Quidel Announces Revised Agreement for Its Pending Acquisition of Alere’s B-type Naturietic Peptide (BNP) Assay Bus. Run on... - br.ADVFN.com
QuidelOrtho’s Earnings Call: Mixed Sentiment Amidst Revenue Decline - TipRanks
QDELQuidel and bioMerieux Announce a Global Strategic Alliance in Rapid Diagnostics - br.ADVFN.com
Where QuidelOrtho Stands With Analysts - Benzinga
QuidelOrtho Stock Gains Following Q4 Earnings Beat, Margins Contract - Yahoo Finance
UBS Raises Price Target on QuidelOrtho to $45 From $43, Maintains Neutral Rating - Marketscreener.com
1.29%
2.68%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):